STOCK TITAN

Carlyle director sells 400K shares at $42.74

A Carlyle Group director reported a charitable gift and an open-market sale of common stock on September 11, 2026.

(Very High)
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

Carlyle Group Inc. (CG) reported that director David M. Rubenstein disclosed two transactions in the company’s common stock dated September 11, 2026. He made a bona fide charitable gift of 100,000 shares, and separately sold 400,000 shares at a weighted average price of $42.74 per share, with individual sale prices ranging from $42.74 to $42.93.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Rubenstein David M.
Role Director
Sold 400,000 shs ($17.10M)
Type Security Shares Price Value
Gift Common Stock F1 100,000 $0.00 $0.00
Sale Common Stock F2 400,000 $42.74 $17.10M
Holdings After Transaction: Common Stock — 26,899,644 shares (Direct)
Footnotes (2)
  1. F1. Reflects a charitable donation by the Reporting Person.
  2. F2. The price reported in column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $42.74 to $42.93, inclusive. The Reporting Person undertakes to provide to The Carlyle Group Inc., any security holder of The Carlyle Group Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.
Gifted shares 100,000 shares Bona fide charitable gift of Carlyle Group common stock on September 11, 2026
Shares sold 400,000 shares Sale of Carlyle Group common stock on September 11, 2026
Weighted average sale price $42.74 per share Weighted average price for 400,000 shares sold, with a range of $42.74–$42.93
Sale price range $42.74 to $42.93 per share Range of individual prices for the 400,000 shares sold
Total shares transacted 500,000 shares Combined total of gifted and sold Carlyle Group common shares
Transaction date September 11, 2026 Date of both the charitable gift and share sale
bona fide gift financial
"The filing describes the 100,000-share transfer as a bona fide gift."
A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.
weighted average price financial
"The price reported is a weighted average price for multiple sale transactions."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
open market or private transaction financial
"The 400,000-share sale is described as an open market or private transaction."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Carlyle Group (CG) report for David M. Rubenstein?

David M. Rubenstein reported a charitable gift of 100,000 Carlyle Group common shares and a separate sale of 400,000 common shares on September 11, 2026.

At what price were the Carlyle Group (CG) shares sold in this Form 4?

The 400,000 Carlyle Group shares were sold at a weighted average price of $42.74 per share, with individual sale prices ranging from $42.74 to $42.93, as disclosed in the footnote.

How many Carlyle Group (CG) shares did David M. Rubenstein donate?

He donated 100,000 shares of Carlyle Group common stock as a charitable contribution, identified in the filing as a bona fide gift.

Were the reported Carlyle Group (CG) transactions under a Rule 10b5-1 plan?

No Rule 10b5-1 trading plan is reported for these transactions; the document-level checkbox indicating trades under such a plan is not selected.

What is the total number of Carlyle Group (CG) shares involved in this Form 4?

The Form 4 covers 500,000 Carlyle Group common shares in total: 100,000 shares transferred as a charitable gift and 400,000 shares sold in the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Rubenstein David M.

(Last)(First)(Middle)
1001 PENNSYLVANIA AVENUE, NW

(Street)
WASHINGTON DISTRICT OF COLUMBIA 20004

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Carlyle Group Inc. [ CG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/11/2026G(1)100,000D$027,299,644D
Common Stock09/11/2026S400,000D$42.74(2)26,899,644D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Reflects a charitable donation by the Reporting Person.
2. The price reported in column 4 is a weighted average price. These securities were sold in multiple transactions at prices ranging from $42.74 to $42.93, inclusive. The Reporting Person undertakes to provide to The Carlyle Group Inc., any security holder of The Carlyle Group Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ Anne K. Frederick by power of attorney for David M. Rubenstein09/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading